Abstract
Numerous findings have allowed the field of microparticles (MP) to progress dramatically from the original discovery of platelet dusts characterizing the phenotypes and functions of these novel subcellular biovectors, investigating the mechanisms of their formation from parental cells, determining their effects on others cells both in physiology and disease states, and translating these notions to disease innovative diagnosis and treatment. The present chapter focuses on platelet-derived MP (PMP) characteristics, biogenesis, and biological roles. After a rapid overview of detection methods, PMP paradoxical functions in disease process and regenerative medicine are discussed, together with future prospects as diagnostic tools and therapeutic agents. PMP are naturally diffusible vectors that play a role in cell/cell communication and deliver active biomolecules. This is believed to have significant pathological implication in the development of several diseases such as cancer, thromboembolism, and atherosclerosis, among others. There is still much research required to understand the paradoxical roles played by PMP in triggering pathological events but also sustaining vessel growth and tissue regeneration. Clinical data linking PMP to pathologies should be interpreted with some caution due to the lack of standardization and technical limitations of methods for PMP exploration that have been applied so far. The recent progress in new methodologies addressing the pitfalls of current techniques in PMP isolation and detection, capable of detecting and counting PMP more accurately, to assess their variability and measure their functional activity, will contribute to a better understanding of their pathological role and also their potential promising use in regenerative medicine.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Agouti I, Cointe S, Robert S, Judicone C, Loundou A, Driss F, Brisson A, Steschenko D, Rose C, Pondarre C, Bernit E, Badens C, Dignat-George F, Lacroix R, Thuret I (2015) Platelet and not erythrocyte microparticles are procoagulant in transfused thalassaemia major patients. Br J Haematol 171:615–624
Arraud N, Linares R, Tan S, Gounou C, Pasquet JM, Mornet S, Brisson AR (2014) Extracellular vesicles from blood plasma: determination of their morphology, size, phenotype and concentration. J Thromb Haemost 12:614–627
Artoni A, Merati G, Padovan L, Scalambrino E, Chantarangkul V, Tripodi A (2012) Residual platelets are the main determinants of microparticles count in frozen-thawed plasma. Thromb Res 130:561–562
Ayers L, Kohler M, Harrison P, Sargent I, Dragovic R, Schaap M, Nieuwland R, Brooks SA, Ferry B (2011) Measurement of circulating cell-derived microparticles by flow cytometry: sources of variability within the assay. Thromb Res 127:370–377
Baj-Krzyworzeka M, Majka M, Pratico D, Ratajczak J, Vilaire G, Kijowski J, Reca R, Janowska-Wieczorek A, Ratajczak MZ (2002) Platelet-derived microparticles stimulate proliferation, survival, adhesion, and chemotaxis of hematopoietic cells. Exp Hematol 30:450–459
Barry OP, Pratico D, Lawson JA, FitzGerald GA (1997) Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. J Clin Invest 99:2118–2127
Barry OP, Pratico D, Savani RC, FitzGerald GA (1998) Modulation of monocyte-endothelial cell interactions by platelet microparticles. J Clin Invest 102:136–144
Barry OP, Kazanietz MG, Pratico D, FitzGerald GA (1999) Arachidonic acid in platelet microparticles up-regulates cyclooxygenase-2-dependent prostaglandin formation via a protein kinase C/mitogen-activated protein kinase-dependent pathway. J Biol Chem 274:7545–7556
Berckmans RJ, Nieuwland R, Boing AN, Romijn FP, Hack CE, Sturk A (2001) Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 85:639–646
Berckmans RJ, Nieuwland R, Tak PP, Boing AN, Romijn FP, Kraan MC, Breedveld FC, Hack CE, Sturk A (2002) Cell-derived microparticles in synovial fluid from inflamed arthritic joints support coagulation exclusively via a factor VII-dependent mechanism. Arthritis Rheum 46:2857–2866
Boilard E, Nigrovic PA, Larabee K, Watts GF, Coblyn JS, Weinblatt ME, Massarotti EM, Remold-O’Donnell E, Farndale RW, Ware J, Lee DM (2010) Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science 327:580–583
Brill A, Dashevsky O, Rivo J, Gozal Y, Varon D (2005) Platelet-derived microparticles induce angiogenesis and stimulate post-ischemic revascularization. Cardiovasc Res 67:30–38
Brunner JD, Lim NK, Schenck S, Duerst A, Dutzler R (2014) X-ray structure of a calcium-activated TMEM16 lipid scramblase. Nature 516:207–212
Bucki R, Pastore JJ, Giraud F, Janmey PA, Sulpice JC (2006) Involvement of the Na+/H+ exchanger in membrane phosphatidylserine exposure during human platelet activation. Biochim Biophys Acta 1761:195–204
Burger D, Schock S, Thompson CS, Montezano AC, Hakim AM, Touyz RM (2013) Microparticles: biomarkers and beyond. Clin Sci (Lond) 124:423–441
Burnouf T, Goubran HA, Chen TM, Ou KL, El-Ekiaby M, Radosevic M (2013) Blood-derived biomaterials and platelet growth factors in regenerative medicine. Blood Rev 27:77–89
Capriotti AL, Caruso G, Cavaliere C, Piovesana S, Samperi R, Lagana A (2013) Proteomic characterization of human platelet-derived microparticles. Anal Chim Acta 776:57–63
Castoldi E, Collins PW, Williamson PL, Bevers EM (2011) Compound heterozygosity for 2 novel TMEM16F mutations in a patient with Scott syndrome. Blood 117:4399–4400
Chahed S, Leroyer AS, Benzerroug M, Gaucher D, Georgescu A, Picaud S, Silvestre JS, Gaudric A, Tedgui A, Massin P, Boulanger CM (2010) Increased vitreous shedding of microparticles in proliferative diabetic retinopathy stimulates endothelial proliferation. Diabetes 59:694–701
Charras GT, Hu CK, Coughlin M, Mitchison TJ (2006) Reassembly of contractile actin cortex in cell blebs. J Cell Biol 175:477–490
Chen TM, Tsai JC, Burnouf T (2010) A novel technique combining platelet gel, skin graft, and fibrin glue for healing recalcitrant lower extremity ulcers. Dermatol Surg 36:453–460
Chow TW, Hellums JD, Thiagarajan P (2000) Thrombin receptor activating peptide (SFLLRN) potentiates shear-induced platelet microvesiculation. J Lab Clin Med 135:66–72
Cloutier N, Tan S, Boudreau LH, Cramb C, Subbaiah R, Lahey L, Albert A, Shnayder R, Gobezie R, Nigrovic PA, Farndale RW, Robinson WH, Brisson A, Lee DM, Boilard E (2013) The exposure of autoantigens by microparticles underlies the formation of potent inflammatory components: the microparticle-associated immune complexes. EMBO Mol Med 5:235–249
Cohen Z, Gonzales RF, Davis-Gorman GF, Copeland JG, McDonagh PF (2002) Thrombin activity and platelet microparticle formation are increased in type 2 diabetic platelets: a potential correlation with caspase activation. Thromb Res 107:217–221
Combes V, Coltel N, Faille D, Wassmer SC, Grau GE (2006) Cerebral malaria: role of microparticles and platelets in alterations of the blood-brain barrier. Int J Parasitol 36:541–546
Coumans FA, van der Pol E, Boing AN, Hajji N, Sturk G, van Leeuwen TG, Nieuwland R (2014) Reproducible extracellular vesicle size and concentration determination with tunable resistive pulse sensing. J Extracell Vesicles 3:25922
Cramer EM, Norol F, Guichard J, Breton-Gorius J, Vainchenker W, Masse JM, Debili N (1997) Ultrastructure of platelet formation by human megakaryocytes cultured with the Mpl ligand. Blood 89:2336–2346
Cunningham CC (1995) Actin polymerization and intracellular solvent flow in cell surface blebbing. J Cell Biol 129:1589–1599
Daleke DL (2003) Regulation of transbilayer plasma membrane phospholipid asymmetry. J Lipid Res 44:233–242
Dashevsky O, Varon D, Brill A (2009) Platelet-derived microparticles promote invasiveness of prostate cancer cells via upregulation of MMP-2 production. Int J Cancer 124:1773–1777
Dean WL, Lee MJ, Cummins TD, Schultz DJ, Powell DW (2009) Proteomic and functional characterisation of platelet microparticle size classes. Thromb Haemost 102:711–718
Denzer K, Kleijmeer MJ, Heijnen HF, Stoorvogel W, Geuze HJ (2000) Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. J Cell Sci 113(Pt 19):3365–3374
Dignat-George F, Boulanger CM (2011) The many faces of endothelial microparticles. Arterioscler Thromb Vasc Biol 31:27–33
Dragovic RA, Gardiner C, Brooks AS, Tannetta DS, Ferguson DJ, Hole P, Carr B, Redman CW, Harris AL, Dobson PJ, Harrison P, Sargent IL (2011) Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis. Nanomedicine 7:780–788
Fackler OT, Grosse R (2008) Cell motility through plasma membrane blebbing. J Cell Biol 181:879–884
Faille D, Combes V, Mitchell AJ, Fontaine A, Juhan-Vague I, Alessi MC, Chimini G, Fusai T, Grau GE (2009) Platelet microparticles: a new player in malaria parasite cytoadherence to human brain endothelium. FASEB J 23:3449–3458
Faille D, El-Assaad F, Mitchell AJ, Alessi MC, Chimini G, Fusai T, Grau GE, Combes V (2012) Endocytosis and intracellular processing of platelet microparticles by brain endothelial cells. J Cell Mol Med 16:1731–1738
Flaumenhaft R (2006) Formation and fate of platelet microparticles. Blood Cells Mol Dis 36:182–187
Flaumenhaft R, Dilks JR, Richardson J, Alden E, Patel-Hett SR, Battinelli E, Klement GL, Sola-Visner M, Italiano JE Jr (2009) Megakaryocyte-derived microparticles: direct visualization and distinction from platelet-derived microparticles. Blood 113:1112–1121
Forlow SB, McEver RP, Nollert MU (2000) Leukocyte-leukocyte interactions mediated by platelet microparticles under flow. Blood 95:1317–1323
Freyssinet JM (2003) Cellular microparticles: what are they bad or good for? J Thromb Haemost 1:1655–1662
Garcia BA, Smalley DM, Cho H, Shabanowitz J, Ley K, Hunt DF (2005) The platelet microparticle proteome. J Proteome Res 4:1516–1521
Gonzalez M, Carlo A, Poncelet P, Boulay-Moine D, Nicham F, Arnaud E, Contant G, Woodhams B (2009) Sensitivity of 2 functional haemostasis assays to platelet-derived microparticles (PMP). J Thromb Haemost 7:Abstract PP-MO-766.
Gruber R, Varga F, Fischer MB, Watzek G (2002) Platelets stimulate proliferation of bone cells: involvement of platelet-derived growth factor, microparticles and membranes. Clin Oral Implants Res 13:529–535
Guervilly C, Lacroix R, Forel JM, Roch A, Camoin-Jau L, Papazian L, Dignat-George F (2011) High levels of circulating leukocyte microparticles are associated with better outcome in acute respiratory distress syndrome. Crit Care 15:R31
Hamon Y, Broccardo C, Chambenoit O, Luciani MF, Toti F, Chaslin S, Freyssinet JM, Devaux PF, McNeish J, Marguet D, Chimini G (2000) ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine. Nat Cell Biol 2:399–406
Hayon Y, Dashevsky O, Shai E, Brill A, Varon D, Leker RR (2012a) Platelet microparticles induce angiogenesis and neurogenesis after cerebral ischemia. Curr Neurovasc Res 9:185–192
Hayon Y, Dashevsky O, Shai E, Varon D, Leker RR (2012b) Platelet microparticles promote neural stem cell proliferation, survival and differentiation. J Mol Neurosci 47:659–665
Headland SE, Jones HR, D’Sa AS, Perretti M, Norling LV (2014) Cutting-edge analysis of extracellular microparticles using ImageStream(X) imaging flow cytometry. Sci Rep 4:5237
Heemskerk JW, Bevers EM, Lindhout T (2002) Platelet activation and blood coagulation. Thromb Haemost 88:186–193
Heijnen HF, Schiel AE, Fijnheer R, Geuze HJ, Sixma JJ (1999) Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 94:3791–3799
Helley D, Banu E, Bouziane A, Banu A, Scotte F, Fischer AM, Oudard S (2009) Platelet microparticles: a potential predictive factor of survival in hormone-refractory prostate cancer patients treated with docetaxel-based chemotherapy. Eur Urol 56:479–484
Hemker HC, Giesen P, AlDieri R, Regnault V, de Smed E, Wagenvoord R, Lecompte T, Beguin S (2002) The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability. Pathophysiol Haemost Thromb 32:249–253
Hoen EN, van der Vlist EJ, Aalberts M, Mertens HC, Bosch BJ, Bartelink W, Mastrobattista E, van Gaal EV, Stoorvogel W, Arkesteijn GJ, Wauben MH (2011) Quantitative and qualitative flow cytometric analysis of nanosized cell-derived membrane vesicles. Nanomedicine 8:712–720
Holme PA, Orvim U, Hamers MJ, Solum NO, Brosstad FR, Barstad RM, Sakariassen KS (1997) Shear-induced platelet activation and platelet microparticle formation at blood flow conditions as in arteries with a severe stenosis. Arterioscler Thromb Vasc Biol 17:646–653
Horstman LL, Ahn YS (1999) Platelet microparticles: a wide-angle perspective. Crit Rev Oncol Hematol 30:111–142
Horstman LL, Jy W, Jimenez JJ, Bidot C, Ahn YS (2004) New horizons in the analysis of circulating cell-derived microparticles. Keio J Med 53:210–230
Horstman LL, Jy W, Minagar A, Bidot CJ, Jimenez JJ, Alexander JS, Ahn YS (2007) Cell-derived microparticles and exosomes in neuroinflammatory disorders. Int Rev Neurobiol 79:227–268
Hottz ED, Medeiros-de-Moraes IM, Vieira-de-Abreu A, de Assis EF, Vals-de-Souza R, Castro-Faria-Neto HC, Weyrich AS, Zimmerman GA, Bozza FA, Bozza PT (2014) Platelet activation and apoptosis modulate monocyte inflammatory responses in dengue. J Immunol 193:1864–1872
Hugel B, Socie G, Vu T, Toti F, Gluckman E, Freyssinet JM, Scrobohaci ML (1999) Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia. Blood 93:3451–3456
Italiano JE Jr, Mairuhu AT, Flaumenhaft R (2010) Clinical relevance of microparticles from platelets and megakaryocytes. Curr Opin Hematol 17:578–584
Iwamoto S, Kawasaki T, Kambayashi J, Ariyoshi H, Monden M (1996) Platelet microparticles: a carrier of platelet-activating factor? Biochem Biophys Res Commun 218:940–944
Jobe SM, Wilson KM, Leo L, Raimondi A, Molkentin JD, Lentz SR, Di Paola J (2008) Critical role for the mitochondrial permeability transition pore and cyclophilin D in platelet activation and thrombosis. Blood 111:1257–1265
Joop K, Berckmans RJ, Nieuwland R, Berkhout J, Romijn FP, Hack CE, Sturk A (2001) Microparticles from patients with multiple organ dysfunction syndrome and sepsis support coagulation through multiple mechanisms. Thromb Haemost 85:810–820
Jy W, Horstman LL, Arce M, Ahn YS (1992) Clinical significance of platelet microparticles in autoimmune thrombocytopenias. J Lab Clin Med 119:334–345
Jy W, Horstman LL, Jimenez JJ, Ahn YS (2004) Measuring circulating cell-derived microparticles. J Thromb Haemost 2:1842–1851
Kim HK, Song KS, Park YS, Kang YH, Lee YJ, Lee KR, Ryu KW, Bae JM, Kim S (2003) Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor. Eur J Cancer 39:184–191
Kim HK, Song KS, Chung JH, Lee KR, Lee SN (2004) Platelet microparticles induce angiogenesis in vitro. Br J Haematol 124:376–384
Knijff-Dutmer EA, Koerts J, Nieuwland R, Kalsbeek-Batenburg EM, van de Laar MA (2002) Elevated levels of platelet microparticles are associated with disease activity in rheumatoid arthritis. Arthritis Rheum 46:1498–1503
Lacroix R, Dignat-George F (2013) Microparticles: new protagonists in pericellular and intravascular proteolysis. Semin Thromb Hemost 39:33–39
Lacroix R, Poncelet P, Robert S, Key N, Dignat-george F (2009) Standardization of flow cytometry-based enumeration of platelet microparticles using calibrated beads: results of instrument qualification. J Thromb Haemost 7(Suppl 2).
Lacroix R, Robert S, Poncelet P, Kasthuri RS, Key NS, Dignat-George F (2010) Standardization of platelet-derived microparticle enumeration by flow cytometry with calibrated beads: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop. J Thromb Haemost 8:2571–2574
Lacroix R, Judicone C, Poncelet P, Robert S, Arnaud L, Sampol J, Dignat-George F (2012a) Impact of pre-analytical parameters on the measurement of circulating microparticles: towards standardization of protocol. J Thromb Haemost 10:437–446
Lacroix R, Plawinski L, Robert S, Doeuvre L, Sabatier F, Martinez de Lizarrondo S, Mezzapesa A, Anfosso F, Leroyer AS, Poullin P, Jourde N, Njock MS, Boulanger CM, Angles-Cano E, Dignat-George F (2012b) Leukocyte- and endothelial-derived microparticles: a circulating source for fibrinolysis. Haematologica 97:1864–1872
Lacroix R, Dubois C, Leroyer AS, Sabatier F, Dignat-George F (2013a) Revisited role of microparticles in arterial and venous thrombosis. J Thromb Haemost 11(Suppl 1):24–35
Lacroix R, Judicone C, Mooberry M, Boucekine M, Key NS, Dignat-George F (2013b) Standardization of pre-analytical variables in plasma microparticle determination: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop. J Thromb Haemost 11:1190–1193
Laffont B, Corduan A, Ple H, Duchez AC, Cloutier N, Boilard E, Provost P (2013) Activated platelets can deliver mRNA regulatory Ago2*microRNA complexes to endothelial cells via microparticles. Blood 122:253–261
Lawrie AS, Albanyan A, Cardigan RA, Mackie IJ, Harrison P (2009) Microparticle sizing by dynamic light scattering in fresh-frozen plasma. Vox Sang 96:206–212
Leroyer AS, Isobe H, Leseche G, Castier Y, Wassef M, Mallat Z, Binder BR, Tedgui A, Boulanger CM (2007) Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. J Am Coll Cardiol 49:772–777
Leytin V, Allen DJ, Mutlu A, Gyulkhandanyan AV, Mykhaylov S, Freedman J (2009) Mitochondrial control of platelet apoptosis: effect of cyclosporin A, an inhibitor of the mitochondrial permeability transition pore. Lab Invest 89:374–384
Li X, Cong H (2009) Platelet-derived microparticles and the potential of glycoprotein IIb/IIIa antagonists in treating acute coronary syndrome. Tex Heart Inst J 36:134–139
Lopez JJ, Salido GM, Pariente JA, Rosado JA (2008) Thrombin induces activation and translocation of Bid, Bax and Bak to the mitochondria in human platelets. J Thromb Haemost 6:1780–1788
Mack M, Kleinschmidt A, Bruhl H, Klier C, Nelson PJ, Cihak J, Plachy J, Stangassinger M, Erfle V, Schlondorff D (2000) Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: a mechanism for cellular human immunodeficiency virus 1 infection. Nat Med 6:769–775
Mallat Z, Hugel B, Ohan J, Leseche G, Freyssinet JM, Tedgui A (1999) Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation 99:348–353
Manno S, Takakuwa Y, Mohandas N (2002) Identification of a functional role for lipid asymmetry in biological membranes: phosphatidylserine-skeletal protein interactions modulate membrane stability. Proc Natl Acad Sci U S A 99:1943–1948
Mause SF, Weber C (2010) Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ Res 107:1047–1057
Mause SF, von Hundelshausen P, Zernecke A, Koenen RR, Weber C (2005) Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium. Arterioscler Thromb Vasc Biol 25:1512–1518
Miyazaki Y, Nomura S, Miyake T, Kagawa H, Kitada C, Taniguchi H, Komiyama Y, Fujimura Y, Ikeda Y, Fukuhara S (1996) High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles. Blood 88:3456–3464
Morel O, Toti F, Hugel B, Freyssinet JM (2004) Cellular microparticles: a disseminated storage pool of bioactive vascular effectors. Curr Opin Hematol 11:156–164
Morel O, Toti F, Hugel B, Bakouboula B, Camoin-Jau L, Dignat-George F, Freyssinet JM (2006) Procoagulant microparticles: disrupting the vascular homeostasis equation? Arterioscler Thromb Vasc Biol 26:2594–2604
Mullier F, Minet V, Bailly N, Devalet B, Douxfils J, Chatelain C, Elalamy I, Dogmé J, Chatelain B (2014) Platelet microparticle generation assay: a valuable test for immune heparin-induced thrombocytopenia diagnosis. Thromb Res 133:1068–1073
Mutschler DK, Larsson AO, Basu S, Nordgren A, Eriksson MB (2002) Effects of mechanical ventilation on platelet microparticles in bronchoalveolar lavage fluid. Thromb Res 108:215–220
Nomura S, Shouzu A, Taomoto K, Togane Y, Goto S, Ozaki Y, Uchiyama S, Ikeda Y (2009) Assessment of an ELISA kit for platelet-derived microparticles by joint research at many institutes in Japan. J Atheroscler Thromb 16:878–887
Nomura S, Omoto S, Yokoi T, Fujita S, Ozasa R, Eguchi N, Shouzu A (2011) Effects of miglitol in platelet-derived microparticle, adiponectin, and selectin level in patients with type 2 diabetes mellitus. Int J Gen Med 4:539–545
Nurden AT, Nurden P, Sanchez M, Andia I, Anitua E (2008) Platelets and wound healing. Front Biosci 13:3532–3548
Ogura H, Kawasaki T, Tanaka H, Koh T, Tanaka R, Ozeki Y, Hosotsubo H, Kuwagata Y, Shimazu T, Sugimoto H (2001) Activated platelets enhance microparticle formation and platelet-leukocyte interaction in severe trauma and sepsis. J Trauma 50:801–809
Ohtsuka M, Sasaki K, Ueno T, Seki R, Nakayoshi T, Koiwaya H, Toyama Y, Yokoyama S, Mitsutake Y, Chibana H, Itaya N, Okamura T, Imaizumi T (2013) Platelet-derived microparticles augment the adhesion and neovascularization capacities of circulating angiogenic cells obtained from atherosclerotic patients. Atherosclerosis 227:275–282
Osumi K, Ozeki Y, Saito S, Nagamura Y, Ito H, Kimura Y, Ogura H, Nomura S (2001) Development and assessment of enzyme immunoassay for platelet-derived microparticles. Thromb Haemost 85:326–330
Owens AP 3rd, Mackman N (2011) Microparticles in hemostasis and thrombosis. Circ Res 108:1284–1297
Park JO, Choi DY, Choi DS, Kim HJ, Kang JW, Jung JH, Lee JH, Kim J, Freeman MR, Lee KY, Gho YS, Kim KP (2013) Identification and characterization of proteins isolated from microvesicles derived from human lung cancer pleural effusions. Proteomics 13:2125–2134
Piguet PF, Vesin C (2002) Modulation of platelet caspases and life-span by anti-platelet antibodies in mice. Eur J Haematol 68:253–261
Poncelet P, Robert S, Bouriche T, Bez J, Lacroix R, Dignat-George F (2015) Standardized counting of circulating platelet microparticles using currently available flow cytometers and scatter-based triggering: forward or side scatter? Cytometry A. doi:10.1002/cyto.a.22685
Prokopi M, Pula G, Mayr U, Devue C, Gallagher J, Xiao Q, Boulanger CM, Westwood N, Urbich C, Willeit J, Steiner M, Breuss J, Xu Q, Kiechl S, Mayr M (2009) Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures. Blood 114:723–732
Puddu P, Puddu GM, Cravero E, Muscari S, Muscari A (2010) The involvement of circulating microparticles in inflammation, coagulation and cardiovascular diseases. Can J Cardiol 26:140–145
Rand ML, Wang H, Bang KW, Packham MA, Freedman J (2006) Rapid clearance of procoagulant platelet-derived microparticles from the circulation of rabbits. J Thromb Haemost 4:1621–1623
Ray DM, Spinelli SL, Pollock SJ, Murant TI, O’Brien JJ, Blumberg N, Francis CW, Taubman MB, Phipps RP (2008) Peroxisome proliferator-activated receptor gamma and retinoid X receptor transcription factors are released from activated human platelets and shed in microparticles. Thromb Haemost 99:86–95
Robert S, Lacroix R, Poncelet P, Harhouri K, Bouriche T, Judicone C, Wischhusen J, Arnaud L, Dignat-George F (2012) High-sensitivity flow cytometry provides access to standardized measurement of small-size microparticles—brief report. Arterioscler Thromb Vasc Biol 32:1054–1058
Rozmyslowicz T, Majka M, Kijowski J, Murphy SL, Conover DO, Poncz M, Ratajczak J, Gaulton GN, Ratajczak MZ (2003) Platelet- and megakaryocyte-derived microparticles transfer CXCR4 receptor to CXCR4-null cells and make them susceptible to infection by X4-HIV. AIDS 17:33–42
Schwertz H, Tolley ND, Foulks JM, Denis MM, Risenmay BW, Buerke M, Tilley RE, Rondina MT, Harris EM, Kraiss LW, Mackman N, Zimmerman GA, Weyrich AS (2006) Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenicity of human platelets. J Exp Med 203:2433–2440
Seigneuret M, Zachowski A, Hermann A, Devaux PF (1984) Asymmetric lipid fluidity in human erythrocyte membrane: new spin-label evidence. Biochemistry 23:4271–4275
Semple JW, Freedman J (2010) Platelets and innate immunity. Cell Mol Life Sci 67:499–511
Shan LY, Li JZ, Zu LY, Niu CG, Ferro A, Zhang YD, Zheng LM, Ji Y (2013) Platelet-derived microparticles are implicated in remote ischemia conditioning in a rat model of cerebral infarction. CNS Neurosci Ther 19:917–925
Shcherbina A, Remold-O’Donnell E (1999) Role of caspase in a subset of human platelet activation responses. Blood 93:4222–4231
Siljander PR (2011) Platelet-derived microparticles—an updated perspective. Thromb Res 127(Suppl 2):S30–S33
Simak J, Gelderman MP (2006) Cell membrane microparticles in blood and blood products: potentially pathogenic agents and diagnostic markers. Transfus Med Rev 20:1–26
Sims PJ, Faioni EM, Wiedmer T, Shattil SJ (1988) Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem 263:18205–18212
Sims PJ, Rollins SA, Wiedmer T (1989) Regulatory control of complement on blood platelets. Modulation of platelet procoagulant responses by a membrane inhibitor of the C5b-9 complex. J Biol Chem 264:19228–19235
Sprague DL, Elzey BD, Crist SA, Waldschmidt TJ, Jensen RJ, Ratliff TL (2008) Platelet-mediated modulation of adaptive immunity: unique delivery of CD154 signal by platelet-derived membrane vesicles. Blood 111:5028–5036
Suzuki J, Umeda M, Sims PJ, Nagata S (2010) Calcium-dependent phospholipid scrambling by TMEM16F. Nature 468(7325):834–838
Thery C, Zitvogel L, Amigorena S (2002) Exosomes: composition, biogenesis and function. Nat Rev Immunol 2:569–579
Toti F, Satta N, Fressinaud E, Meyer D, Freyssinet JM (1996) Scott syndrome, characterized by impaired transmembrane migration of procoagulant phosphatidylserine and hemorrhagic complications, is an inherited disorder. Blood 87:1409–1415
Tzeng YS, Deng SC, Wang CH, Tsai JC, Chen TM, Burnouf T (2013) Treatment of nonhealing diabetic lower extremity ulcers with skin graft and autologous platelet gel: a case series. Biomed Res Int 2013:837620
Untch B, Ahmad S, Jeske WP, Messmore HL, Hoppensteadt DA, Walenga JM, Lietz H, Fareed J (2002) Prevalence, isotype, and functionality of antiheparin-platelet factor 4 antibodies in patients treated with heparin and clinically suspected for heparin-induced thrombocytopenia. The pathogenic role of IgG. Thromb Res 105:117–123
Van Der Meijden PE, Van Schilfgaarde M, Van Oerle R, Renne T, ten Cate H, Spronk HM (2012) Platelet- and erythrocyte-derived microparticles trigger thrombin generation via factor XIIa. J Thromb Haemost 10:1355–1362
van der Pol E, Coumans FA, Grootemaat AE, Gardiner C, Sargent IL, Harrison P, Sturk A, van Leeuwen TG, Nieuwland R (2014) Particle size distribution of exosomes and microvesicles determined by transmission electron microscopy, flow cytometry, nanoparticle tracking analysis, and resistive pulse sensing. J Thromb Haemost 12:1182–1192
van der Zee PM, Biro E, Ko Y, de Winter RJ, Hack CE, Sturk A, Nieuwland R (2006) P-selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction. Clin Chem 52:657–664
Varon D, Shai E (2009) Role of platelet-derived microparticles in angiogenesis and tumor progression. Discov Med 8:237–241
Wang Y, Litvinov RI, Chen X, Bach TL, Lian L, Petrich BG, Monkley SJ, Kanaho Y, Critchley DR, Sasaki T, Birnbaum MJ, Weisel JW, Hartwig J, Abrams CS (2008) Loss of PIP5KIgamma, unlike other PIP5KI isoforms, impairs the integrity of the membrane cytoskeleton in murine megakaryocytes. J Clin Invest 118:812–819
Wang Z, Shi Q, Li S, Du J, Liu J, Dai K (2010) Hyperthermia induces platelet apoptosis and glycoprotein Ibalpha ectodomain shedding. Platelets 21:229–237
Watts JA, Lee YY, Gellar MA, Fulkerson MB, Hwang SI, Kline JA (2012) Proteomics of microparticles after experimental pulmonary embolism. Thromb Res 130:122–128
Wiedmer T, Shattil SJ, Cunningham M, Sims PJ (1990) Role of calcium and calpain in complement-induced vesiculation of the platelet plasma membrane and in the exposure of the platelet factor Va receptor. Biochemistry 29:623–632
Wolf P (1967) The nature and significance of platelet products in human plasma. Br J Haematol 13:269–288
Wu ZH, Ji CL, Li H, Qiu GX, Gao CJ, Weng XS (2013) Membrane microparticles and diseases. Eur Rev Med Pharmacol Sci 17:2420–2427
Xu Y, Nakane N, Maurer-Spurej E (2011) Novel test for microparticles in platelet-rich plasma and platelet concentrates using dynamic light scattering. Transfusion 51:363–370
Yang MY, Chuang H, Chen RF, Yang KD (2002) Reversible phosphatidylserine expression on blood granulocytes related to membrane perturbation but not DNA strand breaks. J Leukoc Biol 71:231–237
Yuana Y, Oosterkamp TH, Bahatyrova S, Ashcroft B, Garcia Rodriguez P, Bertina RM, Osanto S (2010) Atomic force microscopy: a novel approach to the detection of nanosized blood microparticles. J Thromb Haemost 8:315–323
Zhang H, Nimmer PM, Tahir SK, Chen J, Fryer RM, Hahn KR, Iciek LA, Morgan SJ, Nasarre MC, Nelson R, Preusser LC, Reinhart GA, Smith ML, Rosenberg SH, Elmore SW, Tse C (2007) Bcl-2 family proteins are essential for platelet survival. Cell Death Differ 14:943–951
Zhu S, Ma L, Wang S, Chen C, Zhang W, Yang L, Hang W, Nolan JP, Wu L, Yan X (2014) Light-scattering detection below the level of single fluorescent molecules for high-resolution characterization of functional nanoparticles. ACS Nano 8:10998–11006
Zwaal RF, Schroit AJ (1997) Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 89:1121–1132
Zwaal RF, Comfurius P, Bevers EM (1992) Platelet procoagulant activity and microvesicle formation. Its putative role in hemostasis and thrombosis. Biochim Biophys Acta 1180:1–8
Zwicker JI (2008) Tissue factor-bearing microparticles and cancer. Semin Thromb Hemost 34:195–198
Zwicker JI, Lacroix R, Dignat-George F, Furie BC, Furie B (2012) Measurement of platelet microparticles. Methods Mol Biol 788:127–139
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Cointe, S., Lacroix, R., Dignat-George, F. (2017). Platelet-Derived Microparticles. In: Gresele, P., Kleiman, N., Lopez, J., Page, C. (eds) Platelets in Thrombotic and Non-Thrombotic Disorders. Springer, Cham. https://doi.org/10.1007/978-3-319-47462-5_28
Download citation
DOI: https://doi.org/10.1007/978-3-319-47462-5_28
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-47460-1
Online ISBN: 978-3-319-47462-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)